Does ECULIZUMAB Cause Aplastic anaemia? 345 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 345 reports of Aplastic anaemia have been filed in association with ECULIZUMAB (SOLIRIS). This represents 0.8% of all adverse event reports for ECULIZUMAB.
345
Reports of Aplastic anaemia with ECULIZUMAB
0.8%
of all ECULIZUMAB reports
40
Deaths
133
Hospitalizations
How Dangerous Is Aplastic anaemia From ECULIZUMAB?
Of the 345 reports, 40 (11.6%) resulted in death, 133 (38.6%) required hospitalization, and 7 (2.0%) were considered life-threatening.
Is Aplastic anaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ECULIZUMAB. However, 345 reports have been filed with the FAERS database.
What Other Side Effects Does ECULIZUMAB Cause?
Fatigue (4,858)
Off label use (4,228)
Haemoglobin decreased (3,028)
Headache (2,699)
Death (2,221)
Pyrexia (1,948)
Dyspnoea (1,819)
Asthenia (1,732)
Drug ineffective (1,644)
Nausea (1,579)
What Other Drugs Cause Aplastic anaemia?
CYCLOPHOSPHAMIDE (332)
CYCLOSPORINE (331)
METHOTREXATE (281)
BUSULFAN (220)
FLUDARABINE (220)
ETOPOSIDE (186)
VINCRISTINE (173)
CYTARABINE (163)
ELTROMBOPAG OLAMINE (149)
DOXORUBICIN (136)
Which ECULIZUMAB Alternatives Have Lower Aplastic anaemia Risk?
ECULIZUMAB vs EDARAVONE
ECULIZUMAB vs EDETATE
ECULIZUMAB vs EDOXABAN
ECULIZUMAB vs EDOXABAN TOSILATE
ECULIZUMAB vs EFALIZUMAB